5-Amino-1MQ

Metabolic & Weight Loss
Preclinical

5-Amino-1MQ is a small molecule that blocks an enzyme linked to fat storage and metabolic problems. Research focuses on fat cell metabolism, weight loss, and reversing diet-related obesity in animal studies.

Last updated February 22, 2026
4 PubMed-Verified Studies
Popular
Research-Driven Dosage Reports
RouteOral
Dose50–100 mg
Frequency1× daily
Duration4–12 weeks

Based on published research literature.

Swiss Chems|Exclusive Offer
Coupon
10%
Off

Use our affiliate link and code PEPTIDEWIKI at checkout to unlock your 10% discount, every time you use the code.

Shop Now

For research purposes only. PeptideWiki may earn a commission at no extra cost to you.

Overview of 5-Amino-1MQ

Inhibits NNMT enzyme activity in adipose tissue, increasing cellular NAD+ and SAM levels to promote fat cell energy expenditure and shrink adipocytes.

Metabolic / fat reduction

Selectively inhibits NNMT, preventing methylation and degradation of nicotinamide, thereby increasing intracellular NAD+ levels in adipocytes.

Elevated NAD+ activates sirtuin-dependent metabolic pathways (proposed), increasing fat cell energy expenditure and reducing lipid storage.

Increases S-adenosylmethionine (SAM) availability by reducing NNMT-mediated SAM consumption, supporting methylation reactions.

Body composition

Reverses diet-induced obesity in mouse models without changes in food intake or exercise, shrinking adipocyte size.

Reduces total cholesterol levels (proposed), improving lipid profiles in preclinical studies.

Does not cross the blood-brain barrier (proposed), minimizing CNS side effects while targeting peripheral fat metabolism

Read Full 5-Amino-1MQ Dosage Guide

Research-backed dosing protocols, timing, and administration details

Browse more in this category

Metabolic & Weight Loss